Kevin Janot

TL;DR: A significant decrease in patients treated with MTs during the first stages of the COVID epidemic in France and alarming indicators of lengthened care delays are shown, prompting immediate consideration of local and regional stroke networks preparedness in the varying contexts of COVID-19 pandemic evolution.

TL;DR: Thrombectomy alone was not shown to be non-inferior to intravenous alteplase plus thromBectomy and resulted in decreased reperfusion rates, and results do not support omitting intravenousAlteplas before throm bectomy in eligible patients.

TL;DR: This prospective, single-center series with WEB devices used in 39 patients during 3.5 years confirms data from previous multicenter studies that treatment can be accomplished with good safety and efficacy, with a high rate of adequate occlusion.

TL;DR: The efficiency of pre-hospital care chain response and the adequacy of hospital resources are challenged amid the Coronavirus disease 2019 (COVID-19).

TL;DR: Overall number of neurological complications was lower when a lower dose of heparin was administered, and neurovascular studies comparing clopidogrel to ticagrelor and different doses ofHeparin are necessary to demonstrate which association is more efficient with lower complication rates.